Publication & Citation Trends
Publications
28 total
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer PDF
Cited by 61
OpenAlex
MAVERICC, a phase 2 study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV with biomarker stratification as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC).
Cited by 30
OpenAlex
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer PDF
Cited by 495
OpenAlex
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
Cited by 217
OpenAlex
Research Topics
HIV/AIDS drug development and treatment
(12)
HIV Research and Treatment
(10)
Colorectal Cancer Treatments and Studies
(9)
HIV-related health complications and treatments
(7)
Cancer Treatment and Pharmacology
(6)
Affiliations
Research Triangle Park Foundation
Zimmer Biomet (Netherlands)
Baylor College of Medicine
University of Michigan–Ann Arbor
University Hospitals of Cleveland